Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZW) Research & Development (2021 - 2024)

Core Scientific (CORZW) has disclosed Research & Development for 4 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • Quarterly Research & Development rose 167.38% to $5.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Dec 2024, up 64.67% year-over-year, with the annual reading at $11.8 million for FY2024, 64.67% up from the prior year.
  • Research & Development hit $5.0 million in Q4 2024 for Core Scientific, up from $2.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $14.8 million in Q2 2022 to a low of $1.2 million in Q1 2021.
  • Historically, Research & Development has averaged $3.4 million across 4 years, with a median of $2.2 million in 2023.
  • Biggest five-year swings in Research & Development: surged 928.04% in 2022 and later tumbled 88.9% in 2023.
  • Year by year, Research & Development stood at $3.4 million in 2021, then decreased by 22.83% to $2.7 million in 2022, then fell by 29.39% to $1.9 million in 2023, then soared by 167.38% to $5.0 million in 2024.
  • Business Quant data shows Research & Development for CORZW at $5.0 million in Q4 2024, $2.8 million in Q3 2024, and $2.2 million in Q2 2024.